Veriq is a specialist MedTech evidence-generation partner transforming how innovators, manufacturers and investors generate the clinical evidence required for regulatory approval, market access and adoption.
Veriq is a UK-based MedTech clinical trial accelerator built to unlock faster, higher-quality clinical research. Our mission is to transform how medical device and health technology clinical studies are delivered — leveraging the UK’s world-class clinical, academic, and regulatory ecosystem to enable speed, scientific rigour, and cost efficiency.
We bring together a coordinated nationwide network of high-performing orthopaedic and MedTech trial sites, supported by dedicated research nurses, experienced investigators, and leading clinical academics. This pre-primed network enables rapid study set-up, accelerated recruitment, and consistent, high-quality data delivery.
Backed by a leadership team with an exceptional track record in complex, innovative trials, Veriq partners with MedTech developers – from early-stage innovators to global multinationals – to design, execute, and deliver studies on time and on budget.
Veriq is redefining how MedTech innovation reaches patients – faster, smarter, and with uncompromising scientific integrity.
We work with a range of clients from innovative development-stage companies to large multinational companies spanning small-scale to large studies.
Veriq is leveraging the UK’s world-class clinical, academic, and regulatory ecosystem to position the country as the leading global destination for MedTech clinical research
Veriq is a next-generation medtech clinical trials accelerator built on the proven model established by ACT (Accelerating Clinical Trials). ACT’s funded research nurse network has delivered exceptional results in haemato-oncology, dramatically reducing trial set-up times, accelerating patient recruitment, improving data quality, and expanding access to innovative therapies.
Drawing on this successful blueprint, Veriq collaborates closely with ACT founder Professor Charlie Craddock to streamline the pathway from technological innovation to clinical validation. Through this partnership, VerIQ enables medtech developers to initiate and deliver high-quality studies with greater speed, reliability, and operational efficiency.
Access to internationally recognised investigators, research-active clinical sites and specialist clinical expertise across MedTech.
Built exclusively for medical technology studies, with expertise spanning orthopaedics, digital health, AI-enabled devices and emerging technologies.
Integrated support across UKCA, EU MDR and FDA pathways, helping sponsors generate evidence aligned to regulatory and commercial requirements.
Pre-qualified research sites, dedicated study resources and streamlined delivery processes designed to accelerate study start-up and recruitment.
Get in touch to find out more about how we can help design and deliver clinical studies tailored for better outcomes, higher data quality, and faster execution.
Get in touch